Oncology Clinical Trial Management
Specializing in targeted therapeutic oncology trials
Here’s an overview of our experience in oncology clinical trial management. Contact us for more specific details about the trials and how we might be able to assist with your clinical development plan.
Phase II/III targeting pancreatic cancer
Sponsor Type: U.S. public biopharmaceutical company
Sites: 12
Patients: 30
Role: Regulatory matters (Canada), project management, clinical monitoring
Results: Ongoing (as of summer 2008)
Phase II targeting non-small cell lung cancer
Sponsor Type: Governmental body
Sites: 8
Patients: 210
Tasks Performed: Project management, clinical monitoring, SAE reporting, data management.
Results: Ongoing (as of summer 2008)
Phase II targeting malignant ascites
Sponsor Type: Worldwide, European-headquartered medical care company
Sites: 13
Patients: 39
Tasks Performed: Project management, clinical monitoring, medical monitoring, SAE reporting, data management, biostatistics, clinical study report.
Results: Ongoing (as of summer 2008)
Phase II targeting ovarian cancer
Sponsor Type: Worldwide, European-headquartered medical care company
Sites: 10
Patients: 45
Tasks Performed: Project management, clinical monitoring, medical monitoring, SAE reporting, data management, biostatistics, clinical study report.
Results: Ongoing (as of summer 2008)
Phase I targeting metastatic liver cancer, image guided surgery system
Sponsor Type: Private U.S. medical device company
Sites: 3
Patients: 30
Tasks Performed: Project management, clinical monitoring, medical monitoring, SAE reporting, DSMB.
Results: Ongoing (as of summer 2008)
Phase I targeting chronic lymphocytic leukemia
Sponsor Type: Private U.S. biotech
Sites: 4
Patients: 24
Tasks Performed: Project management, clinical monitoring, SAE reporting, data management, biostatistics, clinical study report.
Results: Ongoing (as of summer 2008)
Phase I targeting solid tumors (first-in-human)
Sponsor Type: U.S. public pharmaceutical company
Sites: 3
Patients: 30
Tasks Performed: Project management, clinical monitoring, SAE reporting, data management, biostatistics, clinical study report.
Results: Ongoing (as of summer 2008)
Phase I targeting solid tumors and lymphoma (first-in-human)
Sponsor Type: Global biopharmaceutical company
Sites: 2
Patients: 36
Tasks Performed: Project management, clinical monitoring, medical monitoring and SAE reporting, data management, biostatistics, clinical study report.
Results: Ongoing (as of summer 2008)
Phase I targeting multiple myeloma
Sponsor Type: U.S public biotechnology company
Sites: 6
Patients: 36
Tasks Performed: Project management, clinical monitoring, data management, biostatistics, clinical study report.
Results: Completed 2006
Phase I targeting chronic lymphocytic leukemia
Sponsor Type: U.S public biotechnology company
Sites: 6
Patients: 36
Tasks Performed: Project management, clinical monitoring, data management, biostatistics, clinical study report.
Results: Completed 2006
Phase I targeting solid tumors
Sponsor Type: U.S public biotechnology company
Sites: 3
Patients: 32
Tasks Performed: Project management, clinical monitoring, data management, biostatistics, clinical study report.
Results: Completed 2005